Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $77.4B |
| FY2017, ended Dec 31, 2017 | $80.1B |
| FY2018, ended Dec 31, 2018 | $64.2B |
| FY2019, ended Dec 31, 2019 | $102B |
| FY2020, ended Dec 31, 2020 | $128B |
| FY2021, ended Dec 31, 2021 | $113B |
| FY2022, ended Dec 31, 2022 | $51.8B |
| FY2023, ended Dec 31, 2023 | $56.4B |
| FY2024, ended Dec 31, 2024 | $48.7B |
| FY2025, ended Dec 31, 2025 | $26.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $17.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $29.0B |
| FY2017, ended Dec 31, 2017 | $41.6B |
| FY2018, ended Dec 31, 2018 | $43.6B |
| FY2019, ended Dec 31, 2019 | $45.8B |
| FY2020, ended Dec 31, 2020 | $48.1B |
| FY2021, ended Dec 31, 2021 | $51.7B |
| FY2022, ended Dec 31, 2022 | $54.0B |
| FY2023, ended Dec 31, 2023 | $54.6B |
| FY2024, ended Dec 31, 2024 | $55.1B |
| FY2025, ended Dec 31, 2025 | $54.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $54.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.52B | $2.72B |
| FY2017, ended Dec 31, 2017 | $9.89B | $3.27B |
| FY2018, ended Dec 31, 2018 | $1.23B | $2.64B |
| FY2019, ended Dec 31, 2019 | $1.67B | $4.55B |
| FY2020, ended Dec 31, 2020 | $3.22B | $7.15B |
| FY2021, ended Dec 31, 2021 | $4.65B | $8.60B |
| FY2022, ended Dec 31, 2022 | $5.05B | $5.55B |
| FY2023, ended Dec 31, 2023 | $4.56B | $3.32B |
| FY2024, ended Dec 31, 2024 | $5.08B | $3.16B |
| FY2025, ended Dec 31, 2025 | $4.99B | $4.42B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.92B | $4.36B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.53B |
| FY2017, ended Dec 31, 2017 | $621M |
| FY2018, ended Dec 31, 2018 | $551M |
| FY2019, ended Dec 31, 2019 | $3.48B |
| FY2020, ended Dec 31, 2020 | $1.00B |
| FY2021, ended Dec 31, 2021 | $601M |
| FY2022, ended Dec 31, 2022 | $645M |
| FY2023, ended Dec 31, 2023 | $709M |
| FY2024, ended Dec 31, 2024 | $459M |
| FY2025, ended Dec 31, 2025 | $477M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $509M |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $61.7B |
| FY2017, ended Dec 31, 2017 | $70.2B |
| FY2018, ended Dec 31, 2018 | $72.8B |
| FY2019, ended Dec 31, 2019 | $79.1B |
| FY2020, ended Dec 31, 2020 | $82.8B |
| FY2021, ended Dec 31, 2021 | $91.6B |
| FY2022, ended Dec 31, 2022 | $97.6B |
| FY2023, ended Dec 31, 2023 | $98.2B |
| FY2024, ended Dec 31, 2024 | $94.7B |
| FY2025, ended Dec 31, 2025 | $95.7B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $95.1B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 55.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 269M |
| FY2017, ended Dec 31, 2017 | 239M |
| FY2018, ended Dec 31, 2018 | 225M |
| FY2019, ended Dec 31, 2019 | 210M |
| FY2020, ended Dec 31, 2020 | 194M |
| FY2021, ended Dec 31, 2021 | 173M |
| FY2022, ended Dec 31, 2022 | 153M |
| FY2023, ended Dec 31, 2023 | 145M |
| FY2024, ended Dec 31, 2024 | 142M |
| FY2025, ended Dec 31, 2025 | 127M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 119M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $1.56B | $244M | $5.00B | $32.2B |
| FY2017, ended Dec 31, 2017 | $11.7B | $261M | $0 | — |
| FY2018, ended Dec 31, 2018 | $4.40B | $285M | $0 | — |
| FY2019, ended Dec 31, 2019 | $6.87B | $315M | $0 | — |
| FY2020, ended Dec 31, 2020 | $11.2B | $351M | $23.0M | — |
| FY2021, ended Dec 31, 2021 | $15.4B | $430M | $0 | — |
| FY2022, ended Dec 31, 2022 | $10.3B | $470M | $0 | — |
| FY2023, ended Dec 31, 2023 | $3.21B | $692M | — | — |
| FY2024, ended Dec 31, 2024 | $1.21B | $651M | — | — |
| FY2025, ended Dec 31, 2025 | $5.13B | $673M | — | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.76B | $635M | — | — |
Valuation
At current price- Market Cap
- $12.5B
- P/E
- 2.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 0.2×
- Price / Book
- 0.7×
- EV / EBITDA
- 5.0×
Growth
Trailing 12 months- Revenue (TTM)
- $54.4B
- Revenue Growth YoY
- −1.5%
- Revenue CAGR 3Y
- 0.5%
- Revenue CAGR 5Y
- 2.6%
- EPS Growth YoY
- 5.2%
- Net Income Growth YoY
- −6.5%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 23.3%
- Net Margin
- 9.1%
- FCF Margin
- 8.0%
- Return on Equity
- 29.7%
Earnings
Trailing 12 months- Net Income
- $4.92B
- EPS (diluted)
- $38.43
- EBITDA
- $21.4B
- Operating Income
- $12.7B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $509M
- Total Debt
- $95.1B
- Net Debt
- $94.6B
- Total Assets
- $156B
- Total Liabilities
- $134B
- Shareholders' Equity
- $17.0B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $16.5B
- Capital Expenditure
- $12.1B
- Free Cash Flow
- $4.36B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 0.70
Every ratio is calculated from the company’s reported figures.